214 related articles for article (PubMed ID: 34848177)
21. A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement.
Burzotta F; Aurigemma C; Romagnoli E; Shoeib O; Russo G; Zambrano A; Verdirosi D; Leone AM; Bruno P; Trani C
Catheter Cardiovasc Interv; 2020 Aug; 96(2):459-470. PubMed ID: 31925991
[TBL] [Abstract][Full Text] [Related]
22. Impact of the use of transradial versus transfemoral approach as secondary access in transcatheter aortic valve implantation procedures.
Allende R; Urena M; Cordoba JG; Ribeiro HB; Amat-Santos I; DeLarochellière R; Paradis JM; Doyle D; Mohammadi S; Côté M; Abdul-Jawad O; Del Trigo M; Ortas MR; Laflamme L; Laflamme J; DeLarochellière H; Dumont E; Rodés-Cabau J
Am J Cardiol; 2014 Dec; 114(11):1729-34. PubMed ID: 25439451
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of the percutaneous transaxillary access for transcatheter aortic valve implantation using various transcatheter heart valves in 100 consecutive patients.
Schäfer U; Deuschl F; Schofer N; Frerker C; Schmidt T; Kuck KH; Kreidel F; Schirmer J; Mizote I; Reichenspurner H; Blankenberg S; Treede H; Conradi L
Int J Cardiol; 2017 Apr; 232():247-254. PubMed ID: 28118931
[TBL] [Abstract][Full Text] [Related]
24. Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation.
El-Mawardy M; Schwarz B; Landt M; Sulimov D; Kebernik J; Allali A; Becker B; Toelg R; Richardt G; Abdel-Wahab M
EuroIntervention; 2017 Jan; 12(13):1667-1673. PubMed ID: 28106001
[TBL] [Abstract][Full Text] [Related]
25. Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
Bandali A; Parry-Williams G; Kassam A; Palmer S; Williams PD; de Belder MA; Owens A; Goodwin A; Muir DF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):978-985. PubMed ID: 27189391
[TBL] [Abstract][Full Text] [Related]
26. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
[TBL] [Abstract][Full Text] [Related]
27. Transfemoral transcatheter aortic valve implantation in patients with small diseased peripheral vessels.
Ruparelia N; Buzzatti N; Romano V; Longoni M; Figini F; Montorfano M; Kawamoto H; Miyazaki T; Spagnolo P; Alfieri O; Colombo A; Latib A
Cardiovasc Revasc Med; 2015 Sep; 16(6):326-30. PubMed ID: 26104848
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Frequency of Vascular Complications With Ultrasound-Guided Versus Fluroscopic Roadmap-Guided Femoral Arterial Access in Patients Who Underwent Transcatheter Aortic Valve Implantation.
Potluri SP; Hamandi M; Basra SS; Shinn KV; Tabachnick D; Vasudevan A; Filardo G; DiMaio JM; Brinkman WT; Harrington K; Squiers JJ; Szerlip MI; Brown DL; Holper E; Mack MJ
Am J Cardiol; 2020 Oct; 132():93-99. PubMed ID: 32782067
[TBL] [Abstract][Full Text] [Related]
29. Obesity and vascular complication in percutaneous transfemoral transcatheter aortic valve insertion.
Hosseini M; Lahr BD; Greason KL; Arghami A; Gulati R; Eleid MF; Crestanello JA
Catheter Cardiovasc Interv; 2023 Jun; 101(7):1221-1228. PubMed ID: 37036273
[TBL] [Abstract][Full Text] [Related]
30. Transcatheter aortic valve implantation through distal axillary artery: novel option for vascular access.
Ussia GP; Cammalleri V; Marchetti AA; Sarkar K; De Vico P; Muscoli S; Sergi D; Marchei M; Ippoliti A; Romeo F
J Cardiovasc Med (Hagerstown); 2015 Apr; 16(4):271-8. PubMed ID: 25036268
[TBL] [Abstract][Full Text] [Related]
31. Coronary Access and Percutaneous Coronary Intervention Up to 3 Years After Transcatheter Aortic Valve Implantation With a Balloon-Expandable Valve.
Tarantini G; Nai Fovino L; Le Prince P; Darremont O; Urena M; Bartorelli AL; Vincent F; Hovorka T; Alcalá Navarro Y; Dumonteil N; Ohlmann P; Wendler O
Circ Cardiovasc Interv; 2020 Jul; 13(7):e008972. PubMed ID: 32580586
[TBL] [Abstract][Full Text] [Related]
32. Performing optimal transcatheter aortic valve implantation: The need for tailored use of transcatheter valves.
Fischer Q; Urena M; Bouleti C; Abtan J; Brochet E; Carrasco JL; Iung B; Vahanian A; Himbert D
Arch Cardiovasc Dis; 2019; 112(8-9):512-522. PubMed ID: 31474571
[TBL] [Abstract][Full Text] [Related]
33. Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis.
Yousef A; Simard T; Webb J; Rodés-Cabau J; Costopoulos C; Kochman J; Hernández-Garcia JM; Chiam PT; Welsh RC; Wijeysundera HC; García E; Ribeiro HB; Latib A; Huczek Z; Shanks M; Testa L; Farkouh ME; Dvir D; Velianou JL; Lam BK; Pourdjabbar A; Glover C; Hibbert B; Labinaz M
Int J Cardiol; 2015; 189():282-8. PubMed ID: 25910593
[TBL] [Abstract][Full Text] [Related]
34. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C
Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of transfemoral transcatheter aortic valve implantation (TAVI) and predictors of thirty-day major adverse cardiovascular events (MACE) and one-year mortality.
Eftychiou C; Eteocleous N; Zittis I; Simamonian K; Ioannou A; Loukaidou P; Ntaka A; Hadjigregoriou A; Vasiliades V; Adamou M; Constantinou E; Avraamides P
Hellenic J Cardiol; 2021; 62(1):57-64. PubMed ID: 33007466
[TBL] [Abstract][Full Text] [Related]
36. Ventral calcification in the common femoral artery: A risk factor for major transcatheter aortic valve intervention access site complications.
Staudacher DL; Braxmeier K; Stachon P; Hilgendorf I; Schlett C; Zehender M; von Zur Mühlen C; Bode C; Heidt T
Catheter Cardiovasc Interv; 2021 Nov; 98(6):E947-E953. PubMed ID: 34331732
[TBL] [Abstract][Full Text] [Related]
37. Transcatheter Aortic Valve Implantation in Patients Who Cannot Undergo Transfemoral Access.
Useini D; Beluli B; Christ H; Schlömicher M; Patsalis P; Haldenwang P; Strauch J
Thorac Cardiovasc Surg; 2022 Apr; 70(3):189-198. PubMed ID: 33851408
[TBL] [Abstract][Full Text] [Related]
38. Comparison of clinical outcomes after transcarotid and transsubclavian versus transfemoral transcatheter aortic valve implantation: A propensity-matched analysis.
Villecourt A; Faroux L; Muneaux A; Tassan-Mangina S; Heroguelle V; Poncet A; Nazeyrollas P; Ruggieri VG; Metz D
Arch Cardiovasc Dis; 2020 Mar; 113(3):189-198. PubMed ID: 32037133
[TBL] [Abstract][Full Text] [Related]
39. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
Kodama A; Yamamoto M; Shimura T; Kagase A; Koyama Y; Tada N; Takagi K; Araki M; Yamanaka F; Shirai S; Watanabe Y; Hayashida K
Catheter Cardiovasc Interv; 2017 Sep; 90(3):E55-E62. PubMed ID: 27785881
[TBL] [Abstract][Full Text] [Related]
40. Surgical Management of Percutaneous Transfemoral Access to Minimize Vascular Complications Related to Transcatheter Aortic Valve' Implantation.
Lareyre F; Raffort J; Dommerc C; Habib Y; Bourlon F; Mialhe C
Angiology; 2018 Feb; 69(2):143-150. PubMed ID: 28569069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
